Outcome and Immune Landscape of HER2-positive Invasive Lobular Carcinoma in the North Central Cancer Treatment Group (NCCTG) N9831 (Alliance) Trial
- Citation:
- J Clin Oncol vol 39 (no. 15_suppl) 535
- Meeting Instance:
- ASCO 2021
- Year:
- 2021
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3906
- Pharmas:
- Genentech
- Grants:
- U10CA180821, U24CA196171 , Susan G. Komen SAC190091, BCRF-19-161
- Corr. Author:
- Authors:
- Saranya Chumsri Zhuo Li Tracy Shachner Pooja Advani Kostandinos Sideras Alvaro Moreno-Aspitia Gerardo Colon-Otero Keith L. Knutson Aziza Nassar Edith A. Perez E. Aubrey Thompson.
- Networks:
- LAPS-MN026, NY021, PR028
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: